Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study

By Rogers S.L.   Friedhoff L.T.  

European Neuropsychopharmacology, Vol. 8, Iss. 1, 1998-02 ,pp. : 67-75

Elsevier

Access to resources Recommend Favorite

Long-Term Effects of Rivastigmine Treatment on the Need for Psychotropic Medications in Nursing Home Patients with Alzheimer’s Disease: Results of a 52-Week Open-Label Study

By Edwards Keith  

Clinical Drug Investigation, Vol. 25, Iss. 8, 2005-01 ,pp. : 507-515

Adis International

Access to resources Recommend Favorite

Short-Term Efficacy and Safety of Leflunomide in the Treatment of Active Rheumatoid Arthritis in Everyday Clinical Use: Open-Label, Prospective Study

By Nguyen M.  

Clinical Drug Investigation, Vol. 24, Iss. 2, 2004-01 ,pp. : 103-112

Adis International

Access to resources Recommend Favorite

Long-Term Safety, Tolerability and Efficacy of Fesoterodine in Subjects with Overactive Bladder Symptoms Stratified by Age: Pooled Analysis of Two Open-Label Extension Studies

By Sand Peter K.  

Drugs & Aging, Vol. 29, Iss. 2, 2012-02 ,pp. : 119-131

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of a Stepped-Care Regimen Using Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide in Patients with Moderate-to-Severe Hypertension: An Open-Label, Long-Term Study

By Volpe Massimo   Miele Cristina  

Clinical Drug Investigation, Vol. 29, Iss. 6, 2009-05 ,pp. : 381-391

Adis International

Access to resources Recommend Favorite